Akari Therapeutics plc ADS (NASDAQ: AKTX) Stock Information | RedChip

Akari Therapeutics plc ADS (NASDAQ: AKTX) Listen to this Section


$3.16
-0.1800 ( -5.39% ) 11.9K

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Market Data


Open


$3.16

Previous close


$3.34

Volume


11.9K

Market cap


$37.40M

Day range


$3.00 - $3.33

52 week range


$1.08 - $4.40

Insider Ownership Transactions

Total Amount Purchased: -3,406,955,807.00 | $ -10,765,980,350.12

Date Type Amount Purchased Purchaser
2024-07-02 Sale -5000000.00 Grissinger Michael
2024-07-02 Sale -10000000.00 Prudo-Chlebosz Raymond
2024-07-02 Sale -5000000.00 Hashad Mohamed Wa'el Ahmed
2024-07-02 Sale -5000000.00 WILLIAMS DONALD A
2024-07-02 Sale -91396000.00 Patel Samir Rashmikant
2024-06-04 Sale -1326258000.00 Prudo-Chlebosz Raymond
2024-06-04 Sale -1326258000.00 Patel Samir Rashmikant
2024-05-03 Sale -158473915.00 DICICCO WENDY F
2024-04-30 Sale -479569892.00 Jacques Rachelle Suzanne

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 2 Jul 02, 2024
4 Insider transactions 2 Jul 02, 2024
4 Insider transactions 2 Jul 02, 2024
4 Insider transactions 2 Jul 02, 2024
4 Insider transactions 2 Jul 02, 2024
8-k 8K-related 11 Jul 01, 2024
8-k 8K-related 12 Jun 05, 2024
4 Insider transactions 2 Jun 04, 2024
4 Insider transactions 2 Jun 04, 2024
8-k 8K-related 14 Jun 04, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.